EU begins real-time review of Sanofi-GSK COVID-19 vaccine

The EMA has started a real-time review of Vidprevtyn, the COVID-19 vaccine developed by Sanofi and GSK. /CFP Europe's drug regulator said on Tuesday it had started a real-time review of the CO

CGTN

CGTN

3 Years ago

World well vaccines without were vidprevtyn will world